Aims To evaluate relationships between measures of cognitive functioning and alcohol or drug use among adults (≥ 18 years) in the US general population. Design Two cognitive scales were created based on dimensionality and reliability of self-reported Executive Function Index items. Relationships between the two scales and validators were evaluated. Associations between the cognitive scales and past-year frequency of alcohol or drug use were estimated with adjusted odds ratios (aOR). Setting United States, using the 2012-13 National Epidemiologic Survey on Alcohol and Related Conditions-III, a nationally representative adult sample selected by multi-stage probability sampling. Participants 36 085 respondents. Measurements Past-year substance use outcome variables categorized binge drinking, marijuana, cocaine, opioid, sedative/tranquilizer and stimulant use as frequent (at least weekly to daily), infrequent (any to two to three times/month) or no use, assessed by the Alcohol Use Disorder and Associated Disabilities Interview Schedule-5. Key predictors were the two cognitive scales. Construct validators included education and functional impair- 
INTRODUCTION
Cognitive functioning refers to the mental processes that store, retrieve, transform and use information. Such functioning involves domains such as memory, learning and attention and higher executive functions, e.g. decision-making, organization, planning and control inhibition. Adequate functioning is necessary for important life activities, ranging from simple, e.g. grocery shopping, to complex, e.g. career planning.
Neuropsychological and neuroimaging evidence indicates impaired cognitive functioning in adult patients treated for substance use disorders (SUD) [1] , potentially impacting their ability to utilize treatment [2, 3] or function well in important interpersonal or occupational areas [4, 5] . These cognitive impairments are associated with many substance disorders [6] , including alcohol [7] [8] [9] [10] , cannabis [11] [12] [13] [14] [15] , cocaine [16] [17] [18] [19] [20] [21] [22] [23] [24] and others [25] [26] [27] [28] [29] . In domains including attention and executive functioning, impairments range from mild to severe, as assessed with measures ranging from short tests to extensive neuropsychological batteries.
Whether cognitive functioning is also impaired in general population substance users is unknown. Extant surveys with measures of substance use and cognitive functioning included only middle-aged or older US adults [30] [31] [32] [33] [34] [35] , omitting late adolescent and early adult participants, when prevalence of alcohol and drug use and related disorders is highest [36] [37] [38] . Thus, in large, national samples with participants at the peak ages of risk, information is lacking on the relationship of cognitive functioning to substance use, an increasing health problem with high morbidity and mortality among adults [36, 37, 39] .
The National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) provides nationally representative survey data on US adults ages ≥ 18, including measures of cognition and drug and alcohol use, which can be used to fill the knowledge gap about cognition and substance use and related consequences in the general population. Objective (interviewer-rated) neuropsychological assessments were unfeasible in NESARC-III due to the extensive resources (e.g. interview time, specialized interviewer training) needed. As self-report measures of cognition show moderate to strong relationships to objective measures [40] [41] [42] , particularly when specific cognitive domains are assessed [43] , a brief self-report assessment of cognitive functioning was used, the Executive Function Index (EFI). The EFI is designed to assess specific cognitive domains in adult community surveys, in which it has previously demonstrated good internal consistency and convergent validity [44] .
In this study, we examined the relationships between cognitive functioning and alcohol and drug use in NESARC-III. Before investigating these relationships, information on the psychometric properties of the self-reported EFI items in NESARC-III was needed. Thus, the study was conducted in four steps; we (1) assessed the dimensionality of EFI items, which suggested two underlying factors; (2) estimated the reliability of these factors; (3) assessed the construct and discriminant validity of two scales based on these factors; and (4) estimated the association between these cognitive scales and past-year frequency of binge drinking and drug use.
METHODS

Design
To address the study aim, data from a large, general population US sample were used. We created reliable measures of cognitive functioning, through modeling the dimensionality of the Executive Function Index (EFI) items and assessing the reliability of the resulting factors. Two cognitive scales were derived from the factors and validated by evaluating relationships with construct and discriminant validators. Associations between the frequency of alcohol (binge drinking) or drug use and the cognitive scales were estimated.
Data
The 2012-13 NESARC-III is a nationally representative survey of the non-institutionalized, civilian, adult (aged ≥ 18 years) US population, including residents of households and group quarters [37, 45] . The multi-stage probability sampling scheme included primary sampling units (largely counties) from the entire United States, secondary sampling of groups of census-defined blocks and tertiary sampling of households, with random selection of adults within households [46] . The response rate was 60.1%, comparable to other large-scale national studies [47, 48] . Interviews were face-to-face, using computer-assisted personal interviewing [46] . Interview quality was assured by rigorous interviewer training, supervision and random callbacks to verify responses. Participants provided informed consent and received $90.00. The National Institutes of Health and Westat Institutional Review Boards approved the NESARC-III protocol. This study included 36 085 respondents, after excluding 224 respondents (0.6% of the sample) missing responses for ≥ 25% of the EFI items.
Measures
Outcomes: past-year substance use
The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5) assessed frequency of binge drinking and non-medical substance use, including marijuana, cocaine, opioids, sedatives/tranquilizers and stimulants. AUDADIS-5 alcohol and drug use questions were identical to those in AUDADIS-IV, which showed good-to-excellent test-retest reliability [46, 49] . Frequency of use was indicated by a three-level variable (frequent use, infrequent use, no use), based on how often in the past year respondents engaged in drug use or binge drinking (≥ 5 drinks in a day for men, ≥ 4 for women). Frequent was defined as once a week to daily; infrequent as one to two times in the past year to two to three times a month.
Cognitive functioning
The EFI [44] is a self-reported measure of functioning on cognitive tasks encountered in daily life. NESARC-III included 12 items from the Strategic Planning and Organization EFI subscales to provide brief assessment of domains Substance use and cognition in a US surveywith widely established impairments among patients in treatment for substance use [3, 6, 7] . These subscales previously showed good reliability (α = 0.70 and 0.75, respectively [44] ), and correlated as predicted to demographic characteristics, other cognitive measures and psychological attributes [44, 50, 51] . Items were rated on five-point scales (1 = not at all; 2 = a little; 3 = somewhat; 4 = a lot; 5 = very much). Items that assessed difficulty with functioning ('mix up sequence'; 'trouble multi-tasking'; 'lose track'; 'trouble summing'; 'lose interest') were reverse-coded so that higher response values indicated better functioning, consistent with the other items. Items were summed into scales (see 'Scale construction' below), used as outcomes for validity analyses and then as predictors of substance use.
Validators: predictors of cognitive functioning
Two construct validators were posited. One was education: less than high school, completed high school, some college, college degree and graduate study. Participants with higher education levels were predicted to score higher (positive association) on the cognitive function (EFI) scales. The other was functional impairment, based on the 12-Item Short-Form Health Survey Mental Component Summary (MCS) score, which assesses performing activities less carefully, accomplishing less or social problems due to mental health issues [37, 52] . This score is a reliable and valid measure of current functioning used widely in population surveys, and was used previously for construct validation [53, 54] . To facilitate interpretation, we defined impairment as MCS score in the bottom 25th percentile (≤ 45.8), similar to cut-offs suggested in general population studies [55, 56] . Participants with MCS-based functional impairment were predicted to score lower (negative association) on the cognitive scales. As a sensitivity analysis, we included another functional impairment variable. Respondents were considered to have functional impairment if, when interviewed, they were not functioning in a major role, defined as: full-time employment; full-time student; full-time homemaker; part-time school and employment; or ≥ 65-year-old retiree. This variable was related to the MCS-based variable (χ 2 (1) = 482.53, P ≤ 0.0001). Discriminant validators were hypothesized to have a null relationship to cognitive functioning. These included US Census-defined geographical region (Northeast; Midwest; West; South) and height. Height was dichotomized at the median separately by gender.
Socio-demographic control variables
Covariates that could potentially confound the relationships of interest were included: gender (male, female); age (18-24, 25-44, 45-64, 65-74 
Statistical analysis
Factor analysis
Factor analysis assessed the dimensionality and factor structure of the cognitive items. First, the NESARC-III sample was split into two random splits (SAS version 9.4 [57] ). In split 1, exploratory factor analysis determined the number of factors (dimensions) based on the number of eigenvalues > 1 and standard model fit indices: comparative fit index (CFI), Tucker-Lewis Index (TLI) and root mean square error of approximation (RMSEA), using widely accepted values of good fit (CFI, TLI ≥ 0.95, RMSEA ≤ 0.06) [58] . In split 2, confirmatory factor analysis confirmed the factor structure. In confirmatory factor analysis, the latent factors were parameterized to have mean = 0 and variance = 1, freeing factor loadings for all items. Factor analysis was performed iteratively; when model fit indices indicated poor fit, item loadings and substantive meaning were used to determine items to exclude, until nine items were included in the final item set. Last, confirmatory factor analysis was carried out for the whole data set. Factor analyses were conducted with Mplus version 7.11 [59] , adjusting for the complex sample design and using a weighted least-squares estimator appropriate for categorical items. As 365 participants (1.0% of the sample) were missing one or two EFI items, correlation estimates for each pair of items were calculated among participants with responses for both items (pairwise present analysis), a standard method for low levels of missingness [60] .
Internal consistency (reliability)
Cronbach's alpha was calculated using SAS version 9.4, with α values ≥ 0.65 considered acceptable [61, 62] .
Scale construction
Given the evidence for two latent variables underlying the cognitive function items, two scales were created by summing item responses after recoding responses to 0-4 (instead of 1-5), so that the lowest score = 0 for interpretability. Higher values indicate better functioning. The attention scale included: 'mix up sequence', 'trouble multi-tasking', 'lose track', 'trouble summing' and 'lose interest'. The executive functioning scale included: 'future planning', 'learn from mistakes', 'monitor self' and 'consider consequences'. During summation, mean imputation was used for those missing responses to one to two items; scales were rounded to the nearest integer. Individuals missing greater than or equal to three items were excluded.
Validation
To assess the relationships between the attention and executive scales (dependent outcomes) and the validators (education level, MCS-based functional impairment, region, height in men and in women), 10 linear regression models were analyzed (Supporting information, Table  S1 ). In five models, attention was the outcome, with each model testing one validator (predictor); the other five models were the same, but with executive as the outcome. Following standard epidemiological practice, socio-demographic covariates (age, gender, income, race/ethnicity and education) were included as predictors in the models to control for their effects on the relationships of interest [63] [64] [65] . Due to multiple models, a Bonferronicorrected P-value of 0.05/10 = 0.005 was used to declare significance. SUDAAN version 11.0.1 [66] was used, including sample weights to adjust for the complex sampling and non-response.
Finding that a construct validator showed a stronger relationship to one of the correlated outcomes (attention or executive functioning) would suggest that the scales assessed different domains, supporting two scales. We used Mplus version 7.11 to perform regression of the two scales simultaneously as dependent outcomes, using each validator as a predictor, and controlling for demographic covariates (Supporting information, Table S1 ). Standardized regression coefficients were used so that effects for the two scales could be compared. For each validator subcategory (4 for education, 1 for MCS-based functional impairment), the difference between the standardized effect for the attention and executive scales was estimated; a difference significantly different from 0 indicated a stronger relationship to one of the scales. A Bonferronicorrected P-value of 0.05/5 = 0.01 was used.
Sensitivity analysis
To increase confidence in the MCS-based impairment results, validation analysis was performed for the role-based functional impairment variable. Two linear regression models were analyzed: one for each cognitive scale (dependent outcome), predicted by role-based impairment, controlling for age, gender, income, education and race/ethnicity (Supporting information, Table S1 ).
Associations of substance use and cognition
We explored the relationships between substance use and cognition and vice versa. First, using linear regression with the cognitive scales as the dependent outcomes, we tested whether the mean attention or executive scale scores differed significantly by frequency of use. We analyzed 12 models using SUDAAN version 11.0.1: six models with attention as the outcome, predicted by each of six substance use frequency variables and the socio-demographic covariates; the other six models had the same predictors with executive as the outcome. In each model, the adjusted mean scale score was calculated for each level of the substance use variables [frequent use; infrequent use; no use (reference group)]. A significant regression coefficient for frequent or infrequent use indicated that the mean scale score differed significantly from the mean score for no use.
Secondly, using generalized multinomial logistic regression with substance use frequency as the dependent outcomes, we estimated the unique effects of each cognitive scale on substance use frequency. Six models were analyzed using Mplus version 7.11: one model for each substance use frequency outcome, predicted by both cognitive scales and the socio-demographic covariates, producing adjusted odds ratios (Supporting information, Table  S2 ). Multinomial logistic regression is appropriate for dependent variables with more than two categories (here, frequency of use, with three levels) [67] . To facilitate interpretation, the cognitive scales were standardized (mean = 0; standard deviation = 1), as is common for continuous predictors. Thus, the odds of frequent use (versus no use) or infrequent use (versus no use) were assessed for a one standard deviation decrease in the cognitive scales, corresponding to cut-offs for clinically meaningful cognitive impairment [68, 69] .
RESULTS
Sample characteristics
Approximately half the sample was female, age < 45, income ≥ $20 000; approximately two-thirds were nonHispanic white; and 60% completed at least some college (Supporting information, Table S3 ). Prevalence of substance use ranged from 33% for binge drinking to 1% for cocaine (Table 1) .
Factor analysis
In split 1 of the sample, exploratory factor analysis of the 12 EFI items suggested two factors (two eigenvalues > 1; Supporting information, Table S4 ), but the two-factor model fit indices were below recommended values of 0.95 (CFI = 0.93; TLI = 0.89). To improve model fit, we removed items after considering their substantive meaning, including 'memory strategies' and 'save money', which may assess aspects of personality more than cognition. Exploratory factor analysis of the remaining 10 items led to acceptable two-factor model fit (Supporting information, Table S4 ; CFI = 0.98; TLI = 0.97), but confirmatory factor analysis in split 2 indicated reduced model fit (CFI = 0.96, TLI = 0.94). To improve model fit further, the 'organized' item, which cross-loaded on both factors in the exploratory analysis (Supporting information, Table S4 ), was removed. Exploratory factor analysis (split 1) of the remaining nine items supported a two-factor model based on two eigenvalues > 1 and model fit indices (Table 2 ). Factor 1, labeled 'attention', included 'lose interest', 'mix up sequence', 'lose track' 'trouble multi-tasking' and 'trouble summing up'. Factor 2, labeled 'executive', included 'future planning', 'learn from mistakes', 'monitor self' and 'consider consequences'. Confirmatory factor analysis in split 2 confirmed the factor structure, based on model fit indices: CFI = 0.98; TLI = 0.97; RMSEA = 0.03. Figure 1 shows the confirmatory factor analysis results in the entire sample.
Reliability
Both scales showed acceptable reliability: attention items (α = 0.73); executive items (α = 0.65).
Validity
Attention scale scores were associated as predicted with both construct validators (Table 3 ). Compared to participants who did not complete high school, those who completed high school or more had significantly higher mean attention scores (Table 3) . Those with MCS-based functional impairment had significantly lower mean attention scores, as did those with role-based functional impairment. In contrast, attention scores were not associated significantly with the discriminant validators (Table 3) .
Executive scale scores were associated as predicted with both construct validators (Table 3 ). Compared to participants who did not complete high school, other participants had significantly higher mean executive scores. Those with MCS-based functional impairment had significantly lower mean executive scores, as did those with role-based functional impairment. Executive scores were not associated significantly with the discriminant validators (Table 3 ).
Significant differences in the magnitude of association between the construct validators and the two scales were observed ( Table 3 ). The attention scale showed significantly stronger association with functional impairment (both forms), while the executive scale showed stronger association with education.
Association of cognitive scales and substance use
Linear regressions of substance use predicting the cognitive scales showed that mean scores for the attention and executive scales were significantly lower among those with frequent or infrequent past-year binge drinking or use of marijuana, cocaine, opioids, sedatives/tranquilizers or stimulants, compared to those with no use, except for the executive scale and infrequent binge drinking (Table 1) .
Logistic regressions of cognition predicting substance use showed that for all substances, the attention and executive scales were associated independently and negatively with the frequency of past-year substance use, except for infrequent binge drinking and the executive scale ( Table 4 ). The effects of cognition on the odds of substance use frequency were assessed for a 1 standard deviation decrease in the standardized scales, corresponding to common cut-offs for clinically important impairment [68, 69] . For example, a 1-unit decrease in the attention scale was associated with 1.5 times increased odds of frequent cocaine use and 1.3 times increased odds of infrequent use, independent of the executive scale; a 1-unit decrease in the executive scale was associated with 2.0 and 1.6 times increased odds of frequent or infrequent cocaine use, respectively, independent of the attention scale.
DISCUSSION
In a nationally representative survey of US adults (NESARC-III), nine EFI items fitted a two-factor model representing attention and executive factors, each with acceptable internal consistency. Validity of the attention and executive scales was demonstrated through construct and discriminant validation. Importantly, poorer scores on both the attention and executive scales were associated with the frequency of past-year binge drinking and drug use. This is the first study showing that impairments in attentional and executive aspects of cognitive functioning are associated with frequency of binge drinking and use of marijuana, cocaine, opioids, sedative/tranquilizers and stimulants in the US general population. Similar impairments are well documented in clinical samples of patients with alcohol [70] [71] [72] [73] and drug use disorders [74] [75] [76] [77] [78] .
This study supports using the attention and executive scales in NESARC-III data to investigate further the relationships of cognition to substance use and SUD. While we estimated the associations of cognitive scores with each substance, regardless of other substance use, future studies should determine if observed associations are due to polysubstance use, and whether associations unique to a specific substance are stronger for one aspect of cognition than another. Additional studies should examine the associations of cognition with SUD, course of disorders and treatment utilization. Studies should also determine whether the associations mentioned above differ by socio-demographic characteristics, economic circumstances (e.g. income levels, employment) or psychiatric comorbidity. Results from such studies could generate hypotheses for research involving neuroimaging, such as the Adolescent Brain and Cognition Development (ABCD) study [79] , which follows 10 000 children throughout young adulthood, using structural and functional imaging to investigate the effects of substance use on brain development.
In the cross-sectional NESARC-III survey, whether cognitive impairments precede substance use or vice versa cannot be determined. A reciprocal relationship may exist, in which impairments and substance use influence each other. The longitudinal ABCD study could determine the direction of effect between cognition and substance use/disorders and if specific substances influence particular aspects of cognition by affecting specific areas of the developing brain. However, regardless of direction, poorer cognitive functioning impacts daily life negatively [4, 5] and may cause lack of insight into one's substance use as a source of problems, impeding treatment utilization [80, 81] or decreasing the likelihood of effective treatment [1, 3] . While abstinence or reduced substance use may partially improve cognition [69, 82] , future research should determine whether factors shown to protect against cognitive impairments in aging adults, e.g. healthy diet [83, 84] , physical activity [85] and intellectual activities [86] , also protect against cognitive impairments in populations with difficulties in reducing substance use. ≥$70 000), race/ethnicity (white, black, Native American, Asian/Pacific Islander, Hispanic), and education (less than high school, completed high school, some college, college degree, at least some post-graduate study), using MPlus version 7.11.
Limitations
First, NESARC-III assessed cognitive functioning (planning; temporal sequencing, monitoring self, sustaining attention) with self-reported measures [44] . Although such measures may be subject to inaccuracies due to impaired insight or efforts to conceal deficits, self-reported and objective measures of cognitive performance show moderate to strong relationships [40] [41] [42] , with stronger relationships when specific cognitive domains are assessed [43] , e.g. the attention and executive scales derived from the EFI. Additionally, the EFI assesses consequences of cognitive impairment (e.g. trouble with multi-tasking), rather than directly testing cognition. However, administering standard objective cognitive tests requires resources [87] [88] [89] that are unfeasible for surveys such as NESARC-III. Use of the valid, reliable attention and executive scales will allow investigation of the relationships of cognitive functions to substance-related factors in the general population, which can generate hypotheses for further examination with fullscale objective tests in targeted samples. Secondly, data were cross-sectional; longitudinal studies are warranted to unravel the interplay between cognitive impairments and substance use. Thirdly, as in other national surveys, NESARC-III used self-report rather than biological testing for substance use [39] . While self-report might introduce bias, those with frequent use may report more reliably on use [90] .
Strengths
The NESARC-III sample is nationally representative [46] , large enough to conduct factor analysis in random sample halves, covers a broader age range than previous general population samples with cognition measures [31] [32] [33] [34] [35] and includes measures for a range of substances. The two self-reported scales, which offer the advantages of fast, efficient cognitive data collection [44] , were supported by discriminant and construct validation. Two considerably different functional impairment variables worked the same way, strengthening confidence in the results. Therefore, this study contributes uniquely to the literature and provides reliable, valid attention and executive scales, assessing two related but distinct cognitive domains.
CONCLUSIONS
This study shows the validity of two brief scales assessing key aspects of cognition, attention and executive functioning in a US nationally representative sample. The study demonstrates the association of these cognitive measures with frequency of alcohol and drug use in the general population, indicating that cognitive impairments, shown previously to be associated with substance use in patient samples, constitute a broader problem with more general substance users. Using these scales in NESARC-III data will allow investigation into the relationships of cognitive functioning to polysubstance use, SUD and treatment, advancing our knowledge of substance use, a major public health problem.
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